Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
TXG
#1441
10x Genomics, Inc. Class A Common Stock
23.050
0
+15.37%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+15.37%
Changement Mensuel
+6.71%
Evolution sur 6 mois
+66.79%
Changement Annuel
+66.79%
Clôture Précédente
19.980
0
Open
23.050
0
Bid
Ask
Low
23.050
0
High
23.050
0
Volume
221
Marchés
Actions des Marchés US
Soins de Santé
TXG
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
10x Genomics Inc
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Nouvelles
Canada stocks higher at close of trade; S&P/TSX Composite up 0.61%
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
Priceline, Carvana, DoorDash and more set to report earnings Wednesday
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
L’objectif de prix de l’action 10X Genomics relevé à 22$ contre 20$ par Canaccord Genuity
10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity
Applied Materials and Rivian among market cap stock movers on Friday
Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics
10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates
Le BPA de 10X Genomics a dépassé les attentes de 0,09$, le CA a surpassé les prévisions
10X Genomics face un test de résultats avec le lancement de sa nouvelle stratégie tarifaire
10X Genomics faces earnings test as new pricing strategy debuts